A practical reference on Research chemical: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-04-01 and is reviewed periodically as new material appears.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
Literature on cardarine often separates receptor pharmacology from toxicology. Mechanistic papers describe PPARδ activation and gene expression changes, while safety assessments focus on carcinogenicity and species differences. Questions remain about whether rodent tumors arise through PPARδ-dependent or off-target mechanisms. Another open area is how human metabolism and exposure compare with those in animal studies. Analytical methods such as liquid chromatography–mass spectrometry are used to confirm identity in biological and product samples.
GW501516 acts as an agonist at the peroxisome proliferator-activated receptor delta, a nuclear receptor that regulates gene expression. Activation shifts transcription toward genes involved in fatty acid uptake, oxidation, and energy expenditure. The compound does not bind the androgen receptor and therefore differs from anabolic steroids and SARMs. In rodent models, this metabolic shift has been linked to increased running endurance and reduced fat accumulation. The exact downstream pathways in humans remain incompletely characterized.
Early clinical research explored GW501516 for lipid disorders, obesity, and diabetes. Some short-term human studies reported changes in HDL cholesterol, LDL cholesterol, and triglycerides. The development program was discontinued after rodent studies showed dose-dependent tumor formation in multiple tissues, including liver, bladder, stomach, and skin. These findings raised concerns about long-term cancer risk in humans. Because human exposure data are limited, the clinical significance of the rodent tumors remains uncertain.
| Property | Value | Notes |
|---|---|---|
| Chemical class | PPARδ agonist | Not an anabolic steroid. |
| Common synonyms | GW501516, GW-1516 | Cardarine is an informal name. |
| Appearance | White to off-white powder | Typical for research-grade solid. |
| Solubility class | Poorly soluble in water; soluble in some organic solvents | Such as DMSO or ethanol in laboratory settings. |
| Typical storage temperature | Cool, dry, protected from light | Specific conditions vary by supplier and form. |
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.
Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.
Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.
== Etymology == A loanword from Japanese, umami can be translated as "pleasant savory taste". The original word has various orthographies: うまみ, うま味, 旨味, meaning "deliciousness". However, in its original sense, it is normally used in its adjectival form umai (うまい, 旨い). The arrangement of glyphs うま味 for umami was proposed in 1908 by Kikunae Ikeda to refer to the particular savory component he was researching. While the written forms are often used interchangeably, in the 1980s Japanese researchers suggested that うま味 should be used for the flavor while 旨味 is the more general sense of tasty.
Sometimes distinct from the modern periods themselves, the terms "modernity" and "modernism" refer to a new way of thinking, distinct from previous ways of thinking such as medieval thinking. "Postmodernism", coined in 1949, describes a movement in art rather than a period of history, and is usually applied to arts, but not to any events of recent history. This changed, when postmodernity was coined to describe major changes in the 1960s in economy, society, culture, and philosophy. These terms stem from European history. In worldwide usage, such as in China, India, and Islam, the terms are applied in a different way, but often in the context with their contact with European culture in the Age of Discovery.
Sleep disturbances are common in individuals with ADHD and may arise both from the disorder itself and as an adverse effect of psychostimulant medications, which can cause delayed sleep onset and insomnia. Whilst clonidine's sedative properties, particularly in its immediate-release formulation, can limit its acceptability as a monotherapy for core ADHD symptoms during the daytime, it has been used as a sleep aid in ADHD individuals who are also treated with psychostimulants and experience insomnia. Evidence suggests that immediate-release clonidine taken at bedtime can reduce sleep-onset difficulties and night-time awakenings, but its treatment effects do not persist into the following day and it is therefore not generally effective for daytime ADHD symptoms when used in this manner.
Given the wide range of bacterial, viral, fungal, protozoal, and helminthic pathogens that cause debilitating and life-threatening illnesses, the ability to quickly identify the cause of infection is important yet often challenging. For example, more than half of cases of encephalitis, a severe illness affecting the brain, remain undiagnosed, despite extensive testing using the standard of care (microbiological culture) and state-of-the-art clinical laboratory methods. Metagenomic sequencing-based diagnostic tests are currently being developed for clinical use and show promise as a sensitive, specific, and rapid way to diagnose infection using a single all-encompassing test. This test is similar to current PCR tests; however, an untargeted whole genome amplification is used rather than primers for a specific infectious agent. This amplification step is followed by next-generation sequencing or third-generation sequencing, alignment comparisons, and taxonomic classification using large databases of thousands of pathogen and commensal reference genomes. Simultaneously, antimicrobial resistance genes within pathogen and plasmid genomes are sequenced and aligned to the taxonomically classified pathogen genomes to generate an antimicrobial resistance profile – analogous to antibiotic sensitivity testing – to facilitate antimicrobial stewardship and allow for the optimization of treatment using the most effective drugs for a patient's infection. Metagenomic sequencing could prove especially useful for diagnosis when the patient is immunocompromised.
Christopher Hitchens (13 April 1949 – 15 December 2011) was a British and American author, polemicist, debater and journalist who in his youth took part in demonstrations against the Vietnam War, joined organisations such as the International Socialists while at university and began to identify as a socialist. However, after 9/11 he no longer regarded himself as a socialist and his political thinking became largely dominated by the issue of defending civilization from terrorists and against the totalitarian regimes that protect them. Hitchens nonetheless continued to identify as a Marxist, endorsing the materialist conception of history, but believed that Karl Marx had underestimated the revolutionary nature of capitalism. He sympathized with libertarian ideals of limited state interference, but considered libertarianism not to be a viable system. In the 2000 U.S. presidential election, he supported the Green Party candidate Ralph Nader. After 9/11, Hitchens advocated for the invasion of Iraq. In the 2004 election, he very slightly favored the incumbent Republican President George W. Bush or was neutral and in 2008 he favored the Democratic candidate Barack Obama over John McCain despite being critical of both of them.
Sources: en.wikipedia.org
=== Antidote to heparin === Protamine sulfate has been given to counteract the anticoagulant effect of heparin (1 mg per 100 units of heparin that had been given over the past 6 hours). It may be used in those who overdose on heparin or to reverse heparin's effect when it is no longer needed.
== Etymology == The genus name, Salvia, was first used by Pliny for a plant that was likely Salvia officinalis (common sage) and is derived from the Latin salvere. The specific epithet, divinorum, was given because of the plant's traditional use in divination. It is often loosely translated as "diviner's sage" or "seer's sage". Albert Hofmann, who collected the first plants with Gordon Wasson, objected to the new plant being given the name divinorum: "I was not very happy with the name because Salvia divinorum means 'Salvia of the ghosts,' whereas Salvia divinatorum, the correct name, means 'Salvia of the priests'." It is now in the botanical literature under the name Salvia divinorum due to priority rules.
== Assembly methods == A persistent problem within tissue engineering is mass transport limitations. Engineered tissues generally lack an initial blood supply, thus making it difficult for any implanted cells to obtain sufficient oxygen and nutrients to survive, or function properly.
=== Subcellular membrane fluidity under cold and osmotic stress === The efficiency of lactic acid bacteria cryopreservation is not consistent and may lead to cell death. Lactobacillus delbrueckii subsp. bulgaricus has adapted to defend against cold stress. The way most cells react to the cold is by changing the fluidity of the cellular membrane, but this particular bacterium has acquired different tactics to fight against cold stress. The first way to cope with the cold is to increase viscosity by taking in compounds such as disaccharides, polysaccharides, amino acids and antioxidants. The second strategy used is performed by inducing active responses during the fermentation or post-fermentation processes. By modifying these it will change the temperature, pH and medium composition. This results in specific metabolic pathways becoming active, with the synthesis of cold shock proteins.
Sources: en.wikipedia.org
==== Leukocytes adhesion mediated by shear stress ==== In blood vessel, at very low shear stress of ~.3 dynes per squared centimeter, leukocytes do not adhere to the blood vessel endothelial cells. Cells move along the blood vessel at a rate proportional to the blood flow rate. Once the shear stress pass that shear threshold value, leukocytes start to accumulate via selectin binding. At low shear stress above the threshold of about .3 to 5 dynes per squared centimeter, leukocytes alternate between binding and non-binding. Because one leukocyte has many selectins around the surface, these selectin binding/ unbinding cause a rolling motion on the blood vessel. As the shear stress continue to increase, the selectin bonds becomes stronger, causing the rolling velocity to be slower. This reduction in leukocytes rolling velocity allow cells to stop and perform firm binding via integrin binding. Selectin binding do not exhibit "true" catch bond property. Experiments show that at very high shear stress (passing a second threshold), the selectin binding transit between a catch bond to a slip bond binding, in which the rolling velocity increases as the shear force increases.
=== In microalgal biofilms === EPS is found in the matrix of other microbial biofilms such as microalgal biofilms. The formation of biofilm and structure of EPS share a lot of similarities with bacterial ones. The formation of biofilm starts with reversible absorption of floating cells to the surface. Followed by production of EPS, the adsorption will get irreversible. EPS will colonize the cells at the surface with hydrogen bonding. Replication of early colonizers will be facilitated by the presence of organic molecules in the matrix which will provide nutrients to the algal cells. As the colonizers are reproducing, the biofilm grows and becomes a 3-dimensional structure. Microalgal biofilms consist of 90% EPS and 10% algal cells. Algal EPS has similar components to the bacterial one; it is made up of proteins, phospholipids, polysaccharides, nucleic acids, humic substances, uronic acids and some functional groups, such as phosphoric, carboxylic, hydroxyl and amino groups. Algal cells consume EPS as their source of energy and carbon. Furthermore, EPS protects them from dehydration and reinforces the adhesion of the cells to the surface. In algal biofilms, EPS has two sub-categories; soluble EPS (sEPS) and the bounded EPS (bEPS) with former being distributed in the medium and the latter being attached to the algal cells. Bounded EPS can be further subdivided to tightly bounded EPS (TB-EPS) and loosely bounded EPS (LB-EPS). Several factors contribute to the composition of EPS including species, substrate type, nutrient availability, temperature, pH and light intensity.
=== Final months === In 2004, the team returned after Christmas to long hours, stressful working conditions, and no guarantee that Half-Life 2, which was costing $1 million a month to develop, would be finished soon. However, Newell felt that momentum was gathering, with the team producing about three hours of gameplay per month. In March, they created the first version playable from start to finish and stopped development for a week to play through. Major changes by this point included the cutting of the Borealis, the replacement of the jet ski with an airboat, and introducing the physics-manipulating gravity gun earlier. Feedback was positive across the company. Newell recalled: "The fact that you could go from one end of the game to the other was a really big thing for us. Then we knew it just had to get better – but it was all there." After several months of bug fixes and playtesting, Half-Life 2 was completed on October 13, 2004.
Sources: en.wikipedia.org
Cardarine is commonly known as GW501516 or GW-1516. These names refer to the same synthetic compound. It is not a brand-name approved medicine.
No, cardarine is not a steroid. It is classified as a PPARδ agonist. Its structure and receptor target differ from anabolic steroids.
No regulatory agency has approved cardarine as a medicine. It was investigated in early research but development was discontinued. It is not available as a prescription drug.
It targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not act primarily on androgen receptors. This distinction separates it from SARMs.